Assessment of the safety of recombinant tissue factor pathway inhibitor in patients with severe sepsis: a multicenter, randomized, placebo-controlled, single-blind, dose escalation study.
(Q53320452)
scientific article published in November 2001
scientific article published in November 2001
Language:
other details
description | scientific article published in November 2001 |
External Links
(P356) |
10.1097/00003246-200111000-00007
|
(P698) |
11700399
|